α-TOS has been observed to sensitize resistant leukemia cells to TRAIL-induced apoptosis [76], while TPGS inhibits P-glycoprotein, potentially reversing multidrug resistance in cancer cells [77,78]. This evidence concerns the gene ABCB1 and cancer.